Immunocidin® Equine Now Available in 5mL Format for U.S. Veterinarians

NovaVive Inc.

NovaVive is a private Canadian immunobiology company founded in July, 2014. The Company acquired an advanced veterinary immunotherapeutic platform based on mycobacterium cell wall fraction (MCWF) technology with regulator-approved products for cattle, horses and dogs. These products are currently sold to veterinarians in the U.S.A., Canada, Australia and New Zealand. The Company's head office is located in Belleville, Ontario, Canada.

Sign up to stay up-to-date with NovaVive news.

Recent News

Equine Sarcoid Tumor Product Now Available to U.S. Veterinarians

NovaVive now offers an equine-specific version of its Immunocidin® product for equine sarcoids in response to demand by U.S. veterinarians. Immunocidin® Equine is packaged in 5mL vials for the convenience of practitioners.

learn more

Antibiotic Alternative for Cattle Now Available to Canadian Veterinarians

Amplimune™ is now available to Canadian veterinarians. Amplimune is an immunomodulator that reduces the clinical signs/mortality associated with E. coli diarrhea in neonatal calves. It offers an alternative to antibiotics.

learn more

Antibiotic Alternative for Cattle Approved for Sale in Canada by the Canadian Food Inspection Agency

Amplimune™ has received approval for sale in Canada by the Canadian Food Inspection Agency. The Company believes this is the first antibiotic alternative therapy for livestock to receive Canadian regulatory approval.

learn more

Follow NovaVive on Social Media.